Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Phase II study of sunitinib malate in head and neck squamous cell carcinoma.

Choong NW, Kozloff M, Taber D, Hu HS, Wade J, Ivy P, Karrison TG, Dekker A, Vokes EE, Cohen EE. Phase II study of sunitinib malate in head and neck squamous cell carcinoma. Invest New Drugs. 2010 Oct; 28(5):677-83.

View in: PubMed